# Impact of Supplementation With Synbiotics and Prebiotics on Cognitive Decline Associated With Neoadjuvant Chemotherapy in First-line Patients With Breast Cancer

> **NCT07465497** · NA · ENROLLING_BY_INVITATION · sponsor: **Instituto Jalisciense de Cancerologia** · enrollment: 80 (estimated)

## Conditions studied

- Chemobrain
- Breast Cancer
- Inflammatory Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Synbiotics Blend
- **DIETARY_SUPPLEMENT:** Synbiotics + Vitamin D
- **DIETARY_SUPPLEMENT:** Prebiotic

## Key facts

- **NCT ID:** NCT07465497
- **Lead sponsor:** Instituto Jalisciense de Cancerologia
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-02-27
- **Primary completion:** 2026-12
- **Final completion:** 2027-02
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-03-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07465497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07465497, "Impact of Supplementation With Synbiotics and Prebiotics on Cognitive Decline Associated With Neoadjuvant Chemotherapy in First-line Patients With Breast Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07465497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*